De’Andre James v. State of Arkansas

James, 2026 Ark. App. 103 (Ark. Ct. App. 2026) · Court of Appeals of Arkansas · February 18, 2026 · No. CR-25-46

Summary

The Arkansas Court of Appeals affirmed De’Andre James’s convictions for trafficking fentanyl and maintaining a drug premises within 1,000 feet of a certified drug-free zone. The court held that sufficient circumstantial evidence linked James to the fentanyl and supported the knowing-maintenance conviction, while certain arguments were unpreserved. The court also upheld the admission of expert testimony concerning fentanyl trafficking and concluded that any error regarding testimony about fentanyl’s dangerousness would have been harmless.

Holdings

  1. A defendant is bound on appeal by the nature and scope of the sufficiency arguments made in the directed-verdict motion and may not enlarge those grounds on appeal; James therefore failed to preserve his challenge concerning knowledge that the pills contained fentanyl.
  2. Substantial evidence supported James’s conviction for trafficking fentanyl because the circumstances sufficiently linked him to the fentanyl and established constructive possession.
  3. Substantial evidence established that James knowingly maintained the second bedroom as a premises for drug activity within 1,000 feet of a certified drug-free zone.
  4. James’s argument that the State had to prove a culpable mental state for the drug-free-zone enhancement was not preserved because he did not challenge the jury instruction or raise the issue in his directed-verdict motion.
  5. The circuit court did not abuse its discretion by qualifying Investigator Holland as an expert in fentanyl trafficking and admitting his testimony concerning the mechanics and characteristics of fentanyl trafficking.
  6. Holland’s testimony about fentanyl’s potency and overdose risks was relevant and was not shown to have caused unfair prejudice; even assuming error in admitting some of that testimony, any error was harmless because the evidence of guilt was overwhelming and the testimony did not affect the credibility of the other evidence.

Questions Presented

  1. Whether substantial evidence established that James constructively possessed the fentanyl for purposes of trafficking.
  2. Whether James’s challenge to the sufficiency of the evidence that he knew the pills contained fentanyl was preserved for appellate review.
  3. Whether substantial evidence established that James knowingly maintained a drug premises within 1,000 feet of a certified drug-free zone.
  4. Whether James preserved his argument that the State was required to prove a culpable mental state for the drug-free-zone enhancement.
  5. Whether the circuit court abused its discretion by qualifying Investigator Matthew Holland as an expert in fentanyl trafficking and overdoses.
  6. Whether Holland’s testimony concerning fentanyl’s potency and overdose risks was irrelevant or unfairly prejudicial under Arkansas Rules of Evidence 401 and 403.
  7. Whether any error in admitting testimony concerning fentanyl’s dangerousness and overdose potential was harmless.

Disposition

affirmed

Cases Cited (17)

  • LeFever v. State, 91 Ark. App. 86, 208 S.W.3d 812(followed)
  • Baumann v. State, 2018 Ark. App. 564, 566 S.W.3d 494(followed)
  • James v. State, 2021 Ark. App. 33, 616 S.W.3d 267(followed)
  • Daniels v. State, 2019 Ark. App. 507, 588 S.W.3d 407(followed)
  • Gonzales v. State, 2019 Ark. App. 600, 589 S.W.3d 505(followed)
  • Gibout v. State, 2024 Ark. App. 568, 702 S.W.3d 404(followed)
  • Martin v. State, 2019 Ark. App. 509, 587 S.W.3d 623(followed)
  • Szczerba v. State, 2017 Ark. App. 27, 511 S.W.3d 360(followed)
  • Williams v. State, 2025 Ark. App. 92, 704 S.W.3d 916(followed)
  • Phillips v. State, 344 Ark. 453, 40 S.W.3d 778(followed)

Showing top 10 of 17.

Cited In (0)

No citing cases on record yet.

Court Document

Open PDF
Loading document…